Age-Dependent Development of the Splenic Marginal Zone in Human Infants Is Associated with Different Causes of Death

Human Pathology

Volumn 35, Issue 1, 2004, Pages 113-121

  Kruschinski, Carsten ^b   Zidan, Mohamed ^b   Debertin, Anette S ^b   Von Hörsten, Stephan ^b   Pabst, Reinhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Immunohistochemistry; SID; Spleen development; TI 2 antigen

Indexed keywords

LYMPHOCYTE ANTIGEN; MONOCLONAL ANTIBODY;

AGE; ARTICLE; CADAVER; CAUSE OF DEATH; CHILD; CHILD DEVELOPMENT; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; INFECTION; MALE; NEWBORN; SPLEEN; SUDDEN INFANT DEATH SYNDROME;

EID: 1642580504     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(03)00422-2     Document Type: Article

References (34)

1. Griffioen AW, Franklin SW, Zegers BJ, et al: Expression and functional characteristics of the complement receptor type 2 on adult and neonatal B lymphocytes. Clin Immunol Immunopathol 69:1-8, 1993
2. Llopis MJ, Harms G, Hardonk VP, et al: Human immune response to pneumococcal polysaccharides: Complement-mediated localization preferentially on CD21-positive splenic marginal zone B cells and follicular dendritic cells. J Allergy Clin Immunol 97:1015-1024, 1996
3. Spencer J, Perry ME, Dunn WD: Human marginal-zone B cells. Immunol Today 19:421-426, 1998
4. Timens W, Rozeboom T, Poppema S: Fetal and neonatal development of human spleen: An immunohistological study. Immunology 60:603-609, 1987
5. Shaw JHF, Print CG: Postsplenectomy sepsis. Br J Surg 76: 1074-1081, 1989
6. Timens W, Boes A, Rozeboom-Uiterwijk T, et al: Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J Immunol 143:3200-3206, 1989
7. Hosea SW, Brown EJ, Burch CG, et al: Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine. Lancet I:804-807, 1981
8. Mond JJ, Lees A, Snapper CM: T cell-independent antigens type 2. Annu Rev Immunol 13:655-692, 1995
9. Amlot PL, Grennan D, Humphrey JH: Splenic dependence of the antibody response to thymus-independent (TI-2) antigens. Eur J Immunol 15:508-512, 1985
10. Cyster JG: B cells on the front line. Nat Immun 1:9-10, 2000
11. Guinamard R, Okigaki M, Schlessinger J, et al: Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 1:31-36, 2000
12. Kraal G: Cells in the marginal zone. Int Rev Cytol 132:31-74, 1992
13. Oehen S, Odermatt B, Karrer U, et al: Marginal zone macrophages and immune responses against viruses. J Immunol 169: 1453-1458, 2002
14. Steiniger B, Barth P: Microanatomy and function of the spleen. Adv Anat Embryol Cell Biol 151:1-101, 2000
15. Harms G, Hardonk MJ, Timens W: In vitro complement-depending binding and in vivo kinetics of pneumococcal polysaccharide TI-2 antigens in the rat spleen marginal zone and follicle. Infect Immun 64:4220-4225, 1996
16. Nagler J: Sudden infant death syndrome. Curr Opin Pediatr 14:247-250, 2002
17. Hunt CE: Sudden infant death syndrome and other causes of infant mortality. Diagnosis, mechanisms, and risk for recurrence in siblings. Am J Respir Crit Care Med 164:346-357, 2001
18. Bajanowski T, Ortmann C, Hernandez M, et al: Reaction patterns in selected lymphatic tissues associated with sudden infant death (SID). Int J Legal Med 110:63-68, 1997
19. Sullivan FM, Barlow SM: Review of risk factors for sudden infant death syndrome. Paediatr Perinat Epidemiol 15:144-200, 2001
20. Steiniger B, Barth P, Hellinger A: The perifollicular and marginal zones of the human splenic white pulp-Do fibroblasts guide lymphocyte immigration? Am J Pathol 159:501-512, 2001
21. Zandvoort A, Lodewijk ME, de Boer NK, et al: CD27 expression in the human splenic marginal zone: The infant marginal zone is populated by naive B cells. Tissue Antigens 58:234-242, 2001
22. Timens W, Boes A, Poppema S: Human marginal zone B cells are not an activated B cell subset: Strong expression of CD21 as a putative mediator for rapid B cell activation. Eur J Immunol 19: 2163-2166, 1989
23. Zandvoort A, Timens W: The dual function of the splenic marginal zone: Essential for initiation of anti-TI-2 responses but also vital in the general first-line defense against blood-borne antigens. Clin Exp Immunol 130:4-11, 2002
24. Tangye SG, Liu YJ, Aversa G, et al: Identification of functional human splenic memory B cells by expression of CD148 and CD27. J Exp Med 188:1691-1703, 1998
25. Rothkötter HJ, Ulbrich H, Pabst R: The postnatal development of gut lamina propria lymphocytes: Number, proliferation, and T and B cell subsets in conventional and germ-free pigs. Pediatr Res 29:237-242, 1991
26. Kraal G, Hart JT, Meelhuizen C, et al: Marginal zone macrophages and their role in the immune response against T-independent type 2 antigens: Modulation of the cells with specific antibody. Eur J Immunol 19:675-680, 1989
27. Steiniger B, Barth P, Herbst B, et al: The species-specific structure of microanatomical compartments in the human spleen: Strongly sialoadhesin-positive macrophages occur in the perifollicular zone, but not in the marginal zone. Immunology 92:307-316, 1997
28. Griffioen AW, Toebes EA, Zegers BJ, et al: Role of CR2 in the human adult and neonatal in vitro antibody response to type 4 pneumococcal polysaccharide. Cell Immunol 143:11-22, 1992
29. Humphrey JH, Grennan D: Different macrophage populations distinguished by means of fluorescent polysaccharides: Recognition and properties of marginal zone macrophages. Eur J Immunol 11:221-228, 1981
30. Humphrey JH: Splenic macrophages: Antigen presenting cells for TI-2 antigens. Immunol Lett 11:149-152, 1985
31. Poland GA: The prevention of pneumococcal disease by vaccines: Promises and challenges. Infect Dis Clin N Am 15:97-122, 2001
32. Leemans R, Harms G, Rijkers GT, et al: Spleen autotransplantation provides restoration of functional splenic lymphoid compartments and improves the humoral immune response to pneumococcal polysaccharide vaccine. Clin Exp Immunol 117:596-604, 1999
33. Pabst R, Westermann J, Rothkötter HJ: Immunoarchitecture of regenerated splenic and lymph node transplants. Int Rev Cytol 128:215-260, 1991
34. Leemans R, Manson W, Snijder JAM, et al: Immune response capacity after human splenic autotransplantation: Restoration of response to individual pneumococcal vaccine subtypes. Ann Surg 229: 279-285, 1999